http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Hough, L. E.,Jung, H. T.,Krü,erke, D.,Heberling, M. S.,Nakata, M.,Jones, C. D.,Chen, D.,Link, D. R.,Zasadzinski, J.,Heppke, G.,Rabe, J. P.,Stocker, W.,Kö,rblova, E.,Walba, D. M.,Glaser, M. A. American Association for the Advancement of Scienc 2009 Science Vol.325 No.5939
<P>In the formation of chiral crystals, the tendency for twist in the orientation of neighboring molecules is incompatible with ordering into a lattice: Twist is expelled from planar layers at the expense of local strain. We report the ordered state of a neat material in which a local chiral structure is expressed as twisted layers, a state made possible by spatial limitation of layering to a periodic array of nanoscale filaments. Although made of achiral molecules, the layers in these filaments are twisted and rigorously homochiral--a broken symmetry. The precise structural definition achieved in filament self-assembly enables collective organization into arrays in which an additional broken symmetry--the appearance of macroscopic coherence of the filament twist--produces a liquid crystal phase of helically precessing layers.</P>
조수용(SY hough),이진호(JH Lee),이재억(JA Lee) 대한산부인과학회 1974 Obstetrics & Gynecology Science Vol.17 No.2
hPL-HAIR test kits를 이용하여 정상 및 이상 임신의 각 시기의 임산부 47예와 19예의 태 아제대혈청을 반정량법으로 hPL량을 측정하였다. hPL-HAIR test kits의 감도는 0.1㎍/ml이고 정상 남자의 혈청이나 HCG와는 반응이 없었고 영향을 받지 않았다. 임신 28주 이전까지는 대체로 2㎍/ml이었으며 28주 이후에는 정상임신에서 6∼8㎍/ml로 점 차 증가하는 양상을 보였다. 이는 다른 hPL-Kobe radioimmunoassay 성적과 비교하여 조금 높은 듯 하나 거의 일치하는 성적이었다. 자궁 내 태아사망이나 조산의 경우에는 임신 32주 이후에서 hPL치가 4㎍/ml 또는 그 이하 치를 나타냈는데 Spellacy(1970) 등도 4㎍/ml 이하일 때는 태반기능의 부전증을 의심한다고 발표하였다. 저자 등이 이 kits를 이용하여 측정한 결과도 비슷하다. 많은 예의 실험으로 임 신말기에 정상 하한점을 정확히 판정할 수 있도록 하면 한 번의 hPL 측정치로서도 태반기 능의 부전을 지적할 수 있다고 사료된다. 임신중독증과 자궁근종, 난소종양 및 심장질환이 합병된 임신의 경우 36주 이후에는 hPL치 가 6∼8㎍/ml로서 정상의 범위였다. 태아제대혈청의 hPL치는 대부분 O이고 임산부혈청의 hPL농도와 태아체중과의 관계는 본 실험에서 찾아볼 수 없었다. Plasma levels of human placental lactogen have been measured by hPL-HAIR test kits in 47 pregnant women, in normal and abnormal state, and in 19 cord bloods. 1) Sensitivity of hPL-HAIR test kits was to 0.1㎍/ml of hPL plasma level, had no cross reaction to the HCG or to the male serum, and was not affected by the HCG or by the male serum. 2) hPL value was around 2㎍/ml in first 28 week of pregnancy and was 6∼8㎍/ml after 32 week of pregnancy in normal group. 3) hPL value in intrauterine fetal death or premature labor after 34 week of pregnancy was less than 4㎍/ml. 4) Pregnancy complicated by myoma of the uterus, ovarian tumor, and heary disease showed normal range of hPL at term. 5) hPL value in cord blood was negligible.
호르몬 대체요법시 Dydrogesterone이 지질대사 및 골대사에 미치는 영향
조수용(SY hough),이재관(JK Lee),허준용(JY Hur),서호석(HS Suh),박용균(YK Park),주갑순(KS Ju),임인수(IS Lim),이갑노(KN Lee) 대한산부인과학회 1997 Obstetrics & Gynecology Science Vol.40 No.5
The addition of a monthly course of progesterone decrease the incidence of endometrial hyperplasia and endometrial carcinoma. The progesterones used in hormonal replacement therapy(HRT) differ markedly in their progesteronic, androgenic and even estrogenic activities. These characteristics may influence both symptomatic and metabolic side effects. The purpose of this study was to examine effect of bone and lipid metabolism in postmenopausal women treated with conjugated equine estrogens plus dydrogesterone. A total 131 postmenopausal women(surgical menopause=95, natural menopause=36) and not-treated postmenopausal women(control=22) were invited to participate in this study. Patients were divided into groups which had received conjugated equine estrogen(CEE) 0.625 mg/day 21-day-cycle each month(n=20), CEE 0.625 mg/day plus Dydrogesterone 10 mg/day 10-day-cycle each month(n=111), and no treatment control group(n=20). Serum lipid & lipoprotein(Triglyceride, Total cholesterol, High density lipoprotein, Low density lipoprotein) and serum osteocalcin, urinary Deoxypyridinoline were examined in all patients. There were no significant differences in bone & lipid metabolism between CEE and CEE plus Dydrogesterone groups. In conclusion, Dydrogesterone may be used safely in postmenopausal women without Metabolic side effect.